SPONSOR: Allen
This bill adds xylazine to the list of Schedule III controlled substances as well as any material, compound, mixture, or preparation thereof. The bill provides exceptions, including the prescription or administration of xylazine, or a drug containing xylazine, to an animal, or in the manufacture, use, or distribution of xylazine as an active pharmaceutical ingredient for the purposes of manufacturing an animal drug.
This bill is similar to HB 2749 (2024).
Statutes affected: